Vontobel Holding
ALNY icon

Vontobel Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History

Vontobel Holding’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
5,476
+3,157
+136% +$1.07M 0.01% 547
2025
Q4 		$922K Sell
2,319
-463
-17% -$205K ﹤0.01% 780
2025
Q3 		$1.27M Sell
2,782
-135
-5% -$55K ﹤0.01% 658
2025
Q2 		$951K Buy
2,917
+1,226
+73% +$339K ﹤0.01% 692
2025
Q1 		$457K Sell
1,691
-113
-6% -$29K ﹤0.01% 811
2024
Q4 		$424K Sell
1,804
-5,460
-75% -$1.44M ﹤0.01% 836
2024
Q3 		$2M Sell
7,264
-1,149
-14% -$299K 0.01% 449
2024
Q2 		$2.04M Sell
8,413
-278
-3% -$43.9K 0.01% 425
2024
Q1 		$1.3M Sell
8,691
-242
-3% -$40.4K 0.01% 517
2023
Q4 		$1.71M Buy
8,933
+5,109
+134% +$870K 0.01% 464
2023
Q3 		$677K Sell
3,824
-70
-2% -$13.4K 0.01% 680
2023
Q2 		$740K Sell
3,894
-740
-16% -$147K 0.01% 686
2023
Q1 		$928K Sell
4,634
-671
-13% -$141K 0.01% 606
2022
Q4 		$1.23M Buy
5,305
+459
+9% +$97.9K 0.01% 520
2022
Q3 		$1.01M Sell
4,846
-557
-10% -$106K 0.01% 543
2022
Q2 		$786K Sell
5,403
-1,043
-16% -$148K 0.01% 597
2022
Q1 		$1.06M Sell
6,446
-790
-11% -$120K 0.01% 597
2021
Q4 		$1.24M Buy
7,236
+3,991
+123% +$742K 0.01% 573
2021
Q3 		$612K Buy
3,245
+1,114
+52% +$209K 0.01% 732
2021
Q2 		$354K Sell
2,131
-45
-2% -$6.59K ﹤0.01% 864
2021
Q1 		$307K Hold
2,176
– – ﹤0.01% 798
2020
Q4 		$359K Buy
+2,176
New +$291K ﹤0.01% 756

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vontobel Holding's ALNY Position: Q1 2026 in Review

Vontobel Holding increased its Alnylam Pharmaceuticals (ALNY) stake by 136% in Q1 2026, buying an estimated $1.07M and bringing the position to 5,476 shares worth $1.81M. The position accounts for 0.01% of the portfolio, ranked #547.

Vontobel Holding first reported a position in ALNY in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.04M in Q2 2024. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Vontobel Holding held 5,476 shares of Alnylam Pharmaceuticals worth $1.81M as of Q1 2026.
  • Vontobel Holding bought 3,157 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.07M.
  • Alnylam Pharmaceuticals made up 0.01% of Vontobel Holding's portfolio in Q1 2026, its #547 holding.
  • Vontobel Holding first reported a position in Alnylam Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Alnylam Pharmaceuticals position peaked at $2.04M in Q2 2024.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.